Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16728343rdf:typepubmed:Citationlld:pubmed
pubmed-article:16728343lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C1334507lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C1415855lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16728343lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16728343pubmed:issue4lld:pubmed
pubmed-article:16728343pubmed:dateCreated2006-5-26lld:pubmed
pubmed-article:16728343pubmed:abstractTextThe differential expression of genes and related proteins of multidrug resistance in chemoresistant prostate cancer cell lines were elucidated in this study. RNA extracted from doxorubicin-resistant rat prostate cancer (PCa) cells (AT3/ADR1000) and native PCa cells was hybridized to expression arrays containing cDNAs from 588 known genes. Differential expression of selected genes was confirmed by quantitative reverse-transcription polymerase chain reaction (RT-PCR) analysis. Protein contents were measured by fluorescent flow cytometry and immunoblotting. Localization of selected proteins in cells was observed by immunocytochemical staining. Up-regulation of eleven genes and down-regulation of one single gene were displayed in the chemoresistant prostate cancer cells. Overexpression of mRNAs in macrophage migration inhibitory factor (MIF), DNA binding protein inhibitor 1 (ID1), and glutathione S-transferase-pi (GST-pi) were confirmed by gene-specific RT-PCR. Protein over-expression of GST-pi, MIF, and ID1 in resistant cells were 3.3-, 1.5-, and 1.5-fold to native cells, respectively. Immunocytochemistry revealed that GST-pi, MIF, and ID1 were present primarily in the cytoplasm of tumor cells, but ID1 also could be found in the nucleus. AT3/ADR1000 drug-resistant PCa cells displayed significantly increased expression of GST-pi, MIF, and ID1 proteins when compared with native PCa cells. It indicates these genes may play a role in drug resistance of prostate cancer.lld:pubmed
pubmed-article:16728343pubmed:languageenglld:pubmed
pubmed-article:16728343pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:citationSubsetIMlld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16728343pubmed:statusMEDLINElld:pubmed
pubmed-article:16728343pubmed:issn0148-5016lld:pubmed
pubmed-article:16728343pubmed:authorpubmed-author:ChangS YSYlld:pubmed
pubmed-article:16728343pubmed:authorpubmed-author:HsiehD SDSlld:pubmed
pubmed-article:16728343pubmed:authorpubmed-author:CaiLiLlld:pubmed
pubmed-article:16728343pubmed:issnTypePrintlld:pubmed
pubmed-article:16728343pubmed:volume52lld:pubmed
pubmed-article:16728343pubmed:ownerNLMlld:pubmed
pubmed-article:16728343pubmed:authorsCompleteYlld:pubmed
pubmed-article:16728343pubmed:pagination275-81lld:pubmed
pubmed-article:16728343pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:meshHeadingpubmed-meshheading:16728343...lld:pubmed
pubmed-article:16728343pubmed:articleTitleIncreasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells.lld:pubmed
pubmed-article:16728343pubmed:affiliationUro-Oncology Laboratory, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. yuds@ms21.hinet.netlld:pubmed
pubmed-article:16728343pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16728343pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24426entrezgene:pubmedpubmed-article:16728343lld:entrezgene
entrez-gene:25261entrezgene:pubmedpubmed-article:16728343lld:entrezgene
entrez-gene:81683entrezgene:pubmedpubmed-article:16728343lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16728343lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16728343lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16728343lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16728343lld:pubmed